373 related articles for article (PubMed ID: 19364085)
21. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial.
Azadbakht L; Atabak S; Esmaillzadeh A
Diabetes Care; 2008 Apr; 31(4):648-54. PubMed ID: 18184902
[TBL] [Abstract][Full Text] [Related]
22. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia.
Skulas-Ray AC; West SG; Davidson MH; Kris-Etherton PM
Expert Opin Pharmacother; 2008 May; 9(7):1237-48. PubMed ID: 18422480
[TBL] [Abstract][Full Text] [Related]
23. Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia.
Ristić Medić D; Ristić V; Arsić A; Postić M; Ristić G; Blazencić Mladenović V; Tepsić J
Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):395-404. PubMed ID: 16935698
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men.
Trøseid M; Arnesen H; Hjerkinn EM; Seljeflot I
Metabolism; 2009 Nov; 58(11):1543-9. PubMed ID: 19595382
[TBL] [Abstract][Full Text] [Related]
25. Dietary intakes of alpha-linolenic and linoleic acids are inversely associated with serum C-reactive protein levels among Japanese men.
Poudel-Tandukar K; Nanri A; Matsushita Y; Sasaki S; Ohta M; Sato M; Mizoue T
Nutr Res; 2009 Jun; 29(6):363-70. PubMed ID: 19628101
[TBL] [Abstract][Full Text] [Related]
26. Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia.
Davidson MH; Phillips AK; Kling D; Maki KC
Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1045-54. PubMed ID: 25089906
[TBL] [Abstract][Full Text] [Related]
27. [Effect of the administration of highly-unsaturated fatty acids on the parameters of lipoprotein metabolism and rheology of patients under chronic hemodialysis treatment].
Schmitt Y; Schneider H
Schweiz Med Wochenschr; 1991 Dec; 121(50):1891-4. PubMed ID: 1836897
[TBL] [Abstract][Full Text] [Related]
28. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
[TBL] [Abstract][Full Text] [Related]
29. Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids.
Bays H
Am J Cardiol; 2006 Aug; 98(4A):71i-76i. PubMed ID: 16919519
[TBL] [Abstract][Full Text] [Related]
30. Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II.
Garg ML; Blake RJ; Clayton E; Munro IA; Macdonald-Wicks L; Singh H; Moughan PJ
Eur J Clin Nutr; 2007 Nov; 61(11):1312-7. PubMed ID: 17299483
[TBL] [Abstract][Full Text] [Related]
31. Omega-3 fatty acids for atypical antipsychotic-associated hypertriglyceridemia.
Freeman MP; McInerney K; Sosinsky AZ; Kwiatkowski MA; Cohen LS
Ann Clin Psychiatry; 2015 Aug; 27(3):197-202. PubMed ID: 26247219
[TBL] [Abstract][Full Text] [Related]
32. Effects of low-dose omega-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress--a prospective preliminary study.
Jain S; Gaiha M; Bhattacharjee J; Anuradha S
J Assoc Physicians India; 2002 Aug; 50():1028-33. PubMed ID: 12421024
[TBL] [Abstract][Full Text] [Related]
33. N-3 fatty acids for hypertriglyceridemia in patients taking second-generation antipsychotics.
Fetter JC; Brunette M; Green AI
Clin Schizophr Relat Psychoses; 2013; 7(2):73-77A. PubMed ID: 23367502
[TBL] [Abstract][Full Text] [Related]
34. N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study.
Ide K; Koshizaka M; Tokuyama H; Tokuyama T; Ishikawa T; Maezawa Y; Takemoto M; Yokote K
Lipids Health Dis; 2018 Mar; 17(1):51. PubMed ID: 29544483
[TBL] [Abstract][Full Text] [Related]
35. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
Holub BJ
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
[TBL] [Abstract][Full Text] [Related]
36. Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome.
Benito P; Caballero J; Moreno J; Gutiérrez-Alcántara C; Muñoz C; Rojo G; Garcia S; Soriguer FC
Clin Nutr; 2006 Aug; 25(4):581-7. PubMed ID: 16701922
[TBL] [Abstract][Full Text] [Related]
37. Role of n-3 fatty acids in prevention of disease complications in patients with HIV.
Woods MN
Nutr Clin Care; 2005; 8(1):24-30. PubMed ID: 15850231
[TBL] [Abstract][Full Text] [Related]
38. Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia.
Med Lett Drugs Ther; 2005 Nov; 47(1221):91. PubMed ID: 16267495
[No Abstract] [Full Text] [Related]
39. Nutritional intervention to reduce the n-6/n-3 fatty acid ratio increases adiponectin concentration and fatty acid oxidation in healthy subjects.
Guebre-Egziabher F; Rabasa-Lhoret R; Bonnet F; Bastard JP; Desage M; Skilton MR; Vidal H; Laville M
Eur J Clin Nutr; 2008 Nov; 62(11):1287-93. PubMed ID: 17700650
[TBL] [Abstract][Full Text] [Related]
40. Effects of trans and conjugated LC N-3 polyunsaturated fatty acids on lipid composition and abdominal fat weight in rats.
Okada T; Noguchi R; Hosokawa M; Fukunaga K; Nishiyama T; Zaima N; Hirata T; Miyashita K
J Food Sci; 2008 Oct; 73(8):H201-6. PubMed ID: 19019116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
